Due to a system-wide technology update, we are experiencing extremely high call volume. We appreciate your patience with our operators during this time. Thank you for choosing Fox Chase Cancer Center.
Fox Chase Medical Physicist Receives Outstanding Leadership Award on behalf of Scientists for Accurate Radiation Information
PHILADELPHIA (March 22, 2016) — Mohan Doss, PhD, MCCPM, one of the leading proponents of cancer prevention and treatment using low-dose radiation from Fox Chase Cancer Center, will receive the Outstanding Leadership Award in the field of dose-response on behalf of Scientists for Accurate Radiation Information at the 15th Annual International Conference of the International Dose-Response Society in Amherst, MA.
“I am honored to receive this award on behalf of Scientists for Accurate Radiation Information (SARI),” said Doss, one of the founding members of SARI, and associate professor and medical physicist at Fox Chase. “SARI has taken several initiatives to correct the misinformation about the health effects of low-dose radiation. We in SARI are pleased to receive this recognition of our efforts. Part of our mission at SARI is to help prevent unnecessary, radiation phobia-related deaths, morbidity, and injuries associated with distrust of radio-medical diagnostics/therapies.”
Doss obtained his MS and PhD degrees in physics from Carnegie-Mellon University in Pittsburgh. After 10 years of post-doctoral research in the U.S. and Canada, he became a medical physicist in the Nuclear Medicine department of Regina General Hospital in Regina, Canada. In 2001, he joined the Diagnostic Imaging department of Fox Chase Cancer Center in Philadelphia, where he is presently an associate professor. Doss has board certification in Nuclear Medicine Physics from the Canadian College of Physicists in Medicine.
Doss also individually received the 2014 Outstanding Leadership Award in the field of dose-response from the International Dose-Response Society.
Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence five consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.
For more information, call 888-369-2427